GlassScriptPhysician profile
Roger R Ng
NPI 1659381762
$21,223.49
in general payments reported to CMS, 2019-2025
18 companies · $819 in 2025
The $819 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,602 · 2020: $825 · 2021: $4,084 · 2022: $5,308 · 2023: $7,647 · 2024: $937 · 2025: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,250 · Food and Beverage: $3,140 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,250.00 |
| Food and Beverage | $3,140.20 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omnia Medical, LLC | $8,950.00 | 2022-2023 | |
| Abbott Laboratories | $5,979.31 | 2019-2025 | Proclaim, Eterna, Axium |
| Spinal Simplicity, LLC | $2,686.53 | 2021-2022 | |
| Nevro Corp. | $939.13 | 2019-2024 | Senza |
| Boston Scientific Corporation | $775.68 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $498.14 | 2019-2023 | Xtampza, Belbuca |
| Vertos Medical, INC. | $350.47 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $193.37 | 2019 | |
| Nalu Medical, INC. | $146.05 | 2023 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $144.21 | 2023 | Evoke Scs |
| Globus Medical, INC. | $115.70 | 2025 | Senza |
| Stimwave Technologies Incorporated | $80.60 | 2022 | |
| Medtronic, INC. | $74.90 | 2022-2024 | Intellis Adaptivestim |
| Biotronik INC. | $72.85 | 2025 | Amvia Edge |
| Spr Therapeutics, INC | $70.49 | 2022-2023 | Sprint Pns System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $63.96 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $55.51 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $26.59 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.